Presentation is loading. Please wait.

Presentation is loading. Please wait.

Stephanie B. Clayton, PharmD, Jeffrey R. Acsell, CCP, Arthur J

Similar presentations


Presentation on theme: "Stephanie B. Clayton, PharmD, Jeffrey R. Acsell, CCP, Arthur J"— Presentation transcript:

1 Cardiopulmonary Bypass With Bivalirudin in Type II Heparin-Induced Thrombocytopenia 
Stephanie B. Clayton, PharmD, Jeffrey R. Acsell, CCP, Arthur J. Crumbley, MD, Walter E. Uber, PharmD  The Annals of Thoracic Surgery  Volume 78, Issue 6, Pages (December 2004) DOI: /S (03)

2 Fig 1 Activated clotting time (ACT) and bivalirudin infusion protocol are shown as a function of time in a 74-year-old woman. Bolus doses of bivalirudin were administered as indicated. (# = 107 mg bivalirudin; * = 50 mg bivalirudin; ** = 25 mg bivalirudin.) The Annals of Thoracic Surgery  , DOI: ( /S (03) )

3 Fig 2 Activated clotting time (ACT) and bivalirudin infusion protocol are shown as a function of time in a 67-year-old man. Bolus doses of bivalirudin were administered as indicated. (# = mg bivalirudin; * = 50 mg bivalirudin; ** = 100 mg bivalirudin.) The Annals of Thoracic Surgery  , DOI: ( /S (03) )


Download ppt "Stephanie B. Clayton, PharmD, Jeffrey R. Acsell, CCP, Arthur J"

Similar presentations


Ads by Google